|
Code
|
2169A
|
|
MA number
|
42/0222/99-S
|
|
Product Form:
|
tbl flm 112x500 mg (blis.PVC/Al)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
GlaxoSmithKline Trading Services Limited, Ireland
|
|
Therapeutic Class:
|
42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J05 |
ANTIVIRALS FOR SYSTEMIC USE |
| J05A |
DIRECT ACTING ANTIVIRALS |
| J05AB |
Nucleosides and nucleotides excl. reverse transcriptase |
| J05AB11 |
Valaciclovir |
|
|
Shelf life:
|
36 |
|
Container:
|
blister PVC/Al
|
|
Route of admin.:
|
Oral use
|
SPC_Valtrex 500 mg tbl flm_12.2022.pdf
